PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Materials and Chemical Engineering, Yibin University, Yibin, Sichuan 644000, China.\', \'School of Pharmacy, Xi\'an Jiaotong University, Xi\'an, Shaanxi 710061, China.\', \'Computational Biology/Drug Discovery Laboratory, Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.\', \'School of Pharmacy, Xi\'an Jiaotong University, Xi\'an, Shaanxi 710061, China. Electronic address: wangsc@mail.xjtu.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0753-3322(21)00738-110.1016/j.biopha.2021.111956
?:hasPublicationType
?:journal
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
is ?:pmid of
?:pmid
?:pmid
  • 34332377
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34332377>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34332377>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all